Diversity in itraconazole cocrystals with aliphatic dicarboxylic acids of varying chain length

Crystal Growth and Design

Volumn 13, Issue 11, 2013, Pages 4877-4884

  Shevchenko, Anna ^a,b   Miroshnyk, Inna ^a,c   Pietilä, Lars Olof ^b   Haarala, Jorma ^b   Salmia, Jukka ^b   Sinervo, Kai ^b   Mirza, Sabiruddin ^a,c   Van Veen, Bert ^b   Kolehmainen, Erkki ^d   Nonappa, ^d   Yliruusi, Jouko ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ORION CORPORATION   (Finland)

^c HARVARD UNIVERSITY   (United States)

^d UNIVERSITY OF JYVÄSKYLÄ   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALIPHATIC DICARBOXYLIC ACIDS; ANTIFUNGAL DRUGS; CARBON-CHAIN LENGTH; CO-CRYSTAL FORMATION; DICARBOXYLIC ACID; POWDER X RAY DIFFRACTION; SCREENING TECHNIQUES; SOLID-STATE NUCLEAR MAGNETIC RESONANCE;

ACETONE; HYDRATES; THERMOANALYSIS; X RAY DIFFRACTION;

CHAIN LENGTH;

EID: 84887808968     PISSN: 15287483     EISSN: 15287505     Source Type: Journal    
DOI: 10.1021/cg401061t     Document Type: Article

References (54)

1. Byrn, S. R.; Pfeiffer, R. R.; Stowell, J. G. In Solid-State Chemistry of Drugs; SSCI, Inc: West Lafayette, IN, 1999.
2. Gardner, C. R.; Walsh, C. T.; Almarsson, Ö. Nat. Rev. Drug Discovery 2004, 3, 926-934
3. Balbach, S.; Korn, C. Int. J. Pharm. 2004, 275, 1-12
4. Bauer, J.; Spanton, S.; Henry, R.; Quick, J.; Morris, J. Pharm. Res. 2001, 18, 859-866
5. Huang, L.; Tong, W.-Q. Adv. Drug Delivery Rev. 2004, 56, 321-334
6. Lipinski, C. A. J. Pharmacol. Toxicol. Methods 2000, 44, 235-249
7. Wassvik, C. M.; Holmen, A. G.; Bergstrom, C. A. S.; Zamora, I.; Artursson, P. Eur. J. Pharm. Sci. 2006, 29, 294-305
8. Byrn, S. R.; Henck, J.-O. Optimizing the physical form opportunities and limitations Drug Discovery Today: Technol. 2012, 9, e73-e78
9. Byrn, S. R.; Zografi, G.; Xiaoming, C. Accelerating proof of concept for small molecule drugs using solid-state chemistry J. Pharm. Sci. 2010, 99, 3665-3675
10. Stahly, G. P. Cryst. Growth Des. 2007, 7, 1007-1027
11. Almarsson, Ö.; Zaworotko, M. J. Chem. Commun. 2004, 1889-1896
12. Miroshnyk, I.; Mirza, S.; Sandler, N. Expert Opin. Drug Delivery 2009, 6, 333-341
13. Qiao, N.; Li, M.; Schlindwein, W.; Malek, N.; Davies, A.; Trappitt, G. Int. J. Pharm. 2011, 419, 1-11
14. Steed, J. W. Trends Pharmacol. Sci. 2013, 34, 185-193
15. Vishweshwar, P.; McMahon, J. A.; Bis, J. A.; Zaworotko, M. J. J. Pharm. Sci. 2006, 95, 499-516
16. Brittain, H. G. J. Pharm. Sci. 2013, 102, 311-317
17. Childs, S. L.; Zavorotko, M. J. Cryst. Growth. Des. 2009, 9, 4208-4211
18. Babu, N. J.; Nangia, A. Cryst. Growth. Des. 2011, 11, 2662-2679
19. Bak, A.; Gore, A.; Yanez, E.; Stanton, M.; Tufekcic, S.; Syed, R.; Akrami, A.; Rose, M.; Surapaneni, S.; Bostick, T.; King, A.; Neervannan, S.; Ostovic, D.; Koparkar, A. J. Pharm. Sci. 2008, 97, 3942-3956
20. Bak, A.; Gore, A.; Yanez, E.; Stanton, M.; Tufekcic, S.; Syed, R.; Akrami, A.; Rose, M.; Surapaneni, S.; Bostick, T.; King, A.; Neervannan, S.; Ostovic, D.; Koparkar, A. J. Pharm. Sci. 2008, 97, 3942-3956
21. Friščić, T.; Jones, W. J. Pharm. Pharmacol. 2010, 62, 1547-1559
22. Jones, W.; Motherwell, W. D. S.; Trask, A. V. MRS Bull. 2006, 31, 875-879
23. Blagden, N.; de Matas, M.; Gavan, P. T.; York, P. Adv. Drug Delivery Rev. 2007, 59, 617-630
24. Gao, Y.; Zu, H.; Zhang, J. J. Pharm. Pharmacol. 2011, 63, 483-490
25. Good, D. J.; Rodríguez-Hornedo, N. Cryst. Growth. Des. 2009, 9, 2252-2264
26. McNamara, D. P.; Childs, S. L.; Giordano, J.; Iarriccio, A.; Cassidy, J.; Shet, M. S.; Mannion, R.; O'Donnell, E.; Park, A. Pharm. Res. 2006, 23, 1888-1897
27. Schultheiss, N.; Newman, A. Cryst. Growth. Des. 2009, 9, 2950-2967
28. Thakuria, R.; Delori, A.; Jones, W.; Lipert, M. P.; Roy, L.; Rodríguez-Hornedo, N. Int. J. Pharm. 2013, http://dx.doi.org/10.1016/j. ijpharm.2012.10.043.
29. Weyna, D. R.; Cheney, M. L.; Shan, N.; Hanna, M.; Zaworotko, M. J.; Sava, V.; Song, S.; Sanchez-Ramos, J. Mol. Pharmaceutics 2012, 9, 2094-2102
30. Xu, L.; Chen, J.-M.; Yan, Y.; Lu, T.-B. Cryst. Growth. Des. 2012, 12, 6004-6011
31. Remenar, J. F.; Morissette, S. L.; Peterson, M. L.; Moulton, B.; MacPhee, J. M.; Guzmán, H. R.; Almarsson, Ö. J. Am. Chem. Soc. 2003, 125, 8456-8457
32. Shevchenko, A.; Bimbo, L. M.; Miroshnyk, I.; Haarala, J.; Jelínková, K.; Syrjänen, K.; van Veen, B.; Kiesvaara, J.; Santos, H. A.; Yliruusi, J. Int. J. Pharm. 2012, 436, 403-409
33. Sekhon, B. S. Ars Pharm. 2009, 50, 99
34. Blagden, N.; Berry, D. J.; Parkin, A.; Javed, H.; Ibrahim, A.; Gavan, P. T.; De Matosa, L. L.; Seatona, C. C. New J. Chem. 2008, 32, 1659-1672
35. Morissette, S. L.; Almarsson, Ö.; Peterson, M. L.; Remenar, J. F.; Read, M. J.; Lemmo, A. V.; Ellis, S.; Cima, M. J.; Gardner, C. R. Adv. Drug Delivery Rev. 2004, 56, 275-300
36. Nonappa, N.; Lahtinen, M.; Kolehmainen, M.; Haarala, J.; Shevchenko, A. Cryst. Growth. Des. 2013, 13, 346-351
37. Trask, A. V.; Jones, W. Top. Curr. Chem. 2005, 254, 41-70
38. Fucke, K.; Myz, S. A.; Shakhtshneider, T. P.; Boldyreva, E. V.; Griesser, U. J. New J. Chem. 2012, 36, 1969-1977
39. Myz, S. A.; Shakhtshneider, T. P.; Tumanov, N. A.; Boldyreva, E. V. Russ. Chem. Bull. 2012, 9, 1782-1793
40. Losev, E. A.; Mikhailenko, M. A.; Boldyreva, E. V. Dokl. Phys. Chem. 2011, 439, 153-156
41. Losev, E. A.; Mikhailenko, M. A.; Achkasov, A. F.; Boldyreva, E. V. New J. Chem. 2013, 37, 1973-1981
42. Sheikh, A. Y.; Rahim, S. A.; Hammond, R. B.; Roberts, K. J. CrystEngComm 2009, 11, 501-509
43. Molecular Operating Environment (MOE), 2012.10; Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2012; http://www.chemcomp.com/Research-Current-Journals.htm.
44. deChasteigner, S.; Fessi, H.; Devissaguet, J.-P.; Puisieux, F. Drug Develop. Res. 1996, 38, 125-133
45. Aakeröy, C. B.; Panikkattu, S. V.; DeHaven, B.; Desper, J. Cryst. Growth Des. 2012, 12, 2579-2587
46. Gopalan, S. R.; Kumaradhas, P.; Kulkarni, G. U.; Rao, C. N. R. J. Mol. Struct. 2000, 521, 97-106
47. Nguyen, T. H.; Hibbs, D. E.; Howard, S. T. J. Comput. Chem. 2005, 26, 1233-41
48. Aakeröy, C. B.; Chopade, P. D.; Desper, J. Cryst. Growth. Des. 2011, 11, 5333-5336
49. Housty, J. Acta Crystallogr. 1967, 22, 288-295
50. Chadwick, K.; Davey, R.; Sadiq, G.; Cross, W.; Pritchard, R. CrystEngComm 2009, 11, 412-414
51. Vogt, F. G.; Williams, G. R. Am. Pharm. Rev. 2011, 13 (7) (http://www.americanpharmaceuticalreview.com/Featured-Articles/ 37105-Advanced-Approaches-to-Effective-Solid-state-Analysis-X-Ray-Diffraction- Vibrational-Spectroscopy-and-Solid-state-NMR/).
52. Vogt, F. G.; Clawson, J. S.; Strohmeier, M.; Edwards, A. E.; Pham, T. N.; Watson, S. A. Cryst. Growth. Des. 2008, 9, 921-937
53. Socrates, G. Infrared and Raman Characteristic Group Frequencies Tables and Charts, 3 rd ed.; Wiley: Chichester, West Sussex, England, 2004.
54. Pogorzelec-Glaser, K.; Rachocki, A.; Ławniczak, P.; Pietraszko, A.; Pawlaczyk, C.; Hilczera, B.; Pugaczowa-Michalskaa, M. CrystEngComm 2013, 15, 1950-1959